Ardent Health Earnings Call Highlights Margin Momentum

Ardent Health Partners, Inc. ((ARDT)) has held its Q1 earnings call. Read on for the main highlights of the call.

Ardent Health Partners struck an upbeat tone in its latest earnings call, highlighting solid revenue growth, expanding margins, and disciplined cost control despite some transient headwinds. Management stressed that progress under its IMPACT efficiency program, improved labor trends, and a strong balance sheet are offsetting weather-related volume softness, payer mix pressure, and rising professional and malpractice costs.

Revenue Growth

Ardent reported first quarter revenue of $1.6 billion, a 7% increase versus the prior year, underscoring steady demand across its markets. Management framed this top-line performance as a solid start to 2026, particularly given weather disruptions and a lighter flu season that trimmed some seasonal volumes.

Strong EBITDA and Margin Expansion

Adjusted EBITDA jumped 26% year-over-year to $124 million, pushing the adjusted EBITDA margin up 110 basis points to 7.7%. Even excluding a $10.9 million investment gain, EBITDA rose 15%, while pre-NCI adjusted EBITDAR margin expanded 100 basis points to 11.5%, signaling durable profitability gains.

Volume and Service Line Performance

Adjusted admissions rose 2%, landing at the midpoint of Ardent’s full-year guidance range of 1.5% to 2.5%. Total surgeries increased 1.2% with outpatient procedures up 1.7%, reinforcing the company’s tilt toward higher-margin, lower-acuity surgical settings.

IMPACT Program Savings and Execution

Management said the IMPACT cost-saving program remains on track to deliver $55 million of benefits in 2026, with gains already flowing through the income statement since late 2025. These initiatives are driving structural efficiency, supporting both margin expansion and reinvestment capacity.

Labor and Contract Labor Improvements

Salaries, wages, and benefits expense per adjusted admission declined 1.4% in the quarter, a notable shift in a still-inflationary labor market. Contract labor costs fell more than 40% to $15 million, and contract labor as a share of SW&B dropped from 3.8% to 2.2%, a roughly 160 basis point improvement.

Supply Chain and Cost Controls

Supply expense per adjusted admission rose a modest 1.7%, but supply costs as a percentage of revenue improved by 50 basis points year-over-year. Management credited vendor consolidation, better distribution contracts, and richer rebates for helping to tame non-labor inflation while protecting clinical quality.

Balance Sheet and Liquidity Strength

The company closed the quarter with $610 million of cash, $1.1 billion of total debt, and roughly $0.9 billion of available liquidity. Net leverage sat at 1.0x, while lease-adjusted net leverage improved to 2.6x from 3.0x a year earlier, giving Ardent ample financial flexibility.

Ambulatory and Access Expansion

Ardent continued to push into outpatient care, opening four urgent care centers in Texas, New Mexico, and Idaho during the quarter. For the rest of 2026, it plans two ambulatory surgery centers, one freestanding emergency department, and another urgent care site to drive incremental volume and higher-margin growth.

Technology and Care Transformation Initiatives

The company announced an enterprise-wide AI-assisted virtual care partnership with hellocare.ai covering more than 2,000 patient rooms. Virtual patient monitoring is already live, and management expects the rollout to bolster patient safety and labor efficiency once fully deployed by year-end.

Operational Metrics and Seasonality Management

Improved precision staffing limited SW&B growth to just 0.6% in the quarter, even as volumes shifted due to seasonal factors. Ardent said it mitigated severe winter storms and a light flu season by rescheduling surgeries and flexing labor, preserving both service continuity and cost discipline.

Transient Volume Softness and Weather Impact

Reported admissions declined 1.1% in the quarter, even as adjusted admissions climbed 2%, reflecting case-mix and acuity adjustments. Management tied the headline admission softness to storms in Texas, Oklahoma, and New Jersey and an unusually light respiratory season, describing these effects as transient.

Exchange/Payer Mix Headwind

Ardent reiterated an estimated $35 million EBITDA headwind tied to exchange dynamics, even though exchange admissions rose about 1% to 2%. A roughly 12% shift from silver to bronze plans increased patient cost sharing, reducing realized revenue per case and creating exposure to disenrollments and claw-backs.

Professional Fees Pressure

Professional fees rose 100 basis points as a share of revenue year-over-year, with sequential growth of 2.4% in the first quarter. Management attributed this to compensation dynamics and expects elevated comparisons through mid-year before trends moderate to high single-digit growth in the second half of 2026.

Medical Malpractice Premium Increase

Medical malpractice premiums, particularly in New Mexico, climbed sharply, adding roughly $10 million to $11 million of annualized expense. While recent legislative caps are expected to provide relief over time, management warned that malpractice costs will remain a near-term drag on margins.

Cash Used in Operating Activities

Operating activities consumed $60 million of cash in the quarter compared with $25 million a year earlier, when results benefited from insurance proceeds tied to a prior cybersecurity event. Management noted that the first quarter is typically the weakest for cash flow due to payment timing on year-end accruals.

Denials and Revenue Recovery Risk

Payer denials remain elevated across the industry, and Ardent said levels were stable versus the fourth quarter of 2025 but still a risk to revenue integrity. The company is working with its revenue cycle partner Ensemble to tighten denial management and improve recoveries, though underpayments and contested claims remain a recurring challenge.

Guidance and Outlook

Ardent reaffirmed its full-year revenue and adjusted EBITDA guidance, as well as its adjusted admissions growth target of 1.5% to 2.5% for 2026. Management emphasized prudence in not raising guidance after a strong first quarter, citing ongoing exchange-related pressure and macro uncertainty, while confirming the IMPACT program’s $55 million savings target remains intact.

Ardent’s latest earnings call painted a picture of a hospital operator steadily improving profitability through disciplined cost control and targeted growth, even as it navigates payer mix shifts and regulatory cost pressures. For investors, the story is one of measured optimism: expanding margins, healthy leverage, and a robust pipeline of ambulatory and technology initiatives balanced against reimbursement risk and rising professional and malpractice expenses.